Breaking News

Financial Report: Sanofi

August 8, 2014

Pharma sales up 7% in the quarter


2Q Revenues: €8.1 billion (+1%)

2Q Earnings: €1.5 billion (+4%)

YTD Revenues: €15.9 billion (-1%)

YTD Earnings: €3.1 billion (flat)

Comments: Pharmaceutical sales were up 7% to €6.8 billion. Diabetes division sales were up 16% to €1.8 billion in the quarter driven by Lantus (up 16% to €1.6 billion). Genzyme sales were up 29% to €643 million, driven by the growth of Aubagio and Fabrazyme. Sanofi Pasteur sales were flat at €718 million reflecting continued gradual recovery of Pentacel, strong performance of Flu vaccines, which was offset by lower Booster vaccines sales. Consumer Healthcare sales were €816 million, up 20%.
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments